Literature DB >> 166919

Occurrence of BK virus and BK virus-specific antibodies in the urine of patients receiving chemotherapy for malignancy.

J M Reese, M Reissing, R W Daniel, K V Shah.   

Abstract

Urine specimens from 23 children and 9 adults who were undergoing treatment for malignancy as well as urines from 40 normal individuals were concentrated and examined for evidence of papovavirus infection. Papovavirus particles were detected in 6 of 64 urines examined by electron microscopy. Three of the particle-positive urines induced BK virus-specific immunofluorescence after inoculation of WI38 cells, and three isolations of BK virus were made by inoculation of urines from virus-excreting patients into Vero cells. BK virus-specific hemagglutination-inhibiting and immunofluorescence neutralizing antibodies were found in a majority of urines from adult patients, in about a fifth of pediatric patients, and less often in normal urines. Urines of virus-excreting patients generally had antibodies. In indirect fluorescent antibody tests, BK virus-specific antibodies of the immunoglobulin G class were found in five urine specimens from patients; immunoglobulin A antibodies were not detected in any urine. These data suggest that activation of BK virus is related to immunosuppression and not to transplantation itself and that the occurrence of virus-specific antibodies in urine may be indicative of virus multiplication in the urinary tract.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 166919      PMCID: PMC415225          DOI: 10.1128/iai.11.6.1375-1381.1975

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  13 in total

1.  Induced latent infection of monkeys with vacuolating SV-40 Papova virus. Virus in kidneys and urine.

Authors:  A ASHKENAZI; J L MELNICK
Journal:  Proc Soc Exp Biol Med       Date:  1962-11

2.  Neutralizing antibody to polioviruses in normal human urine.

Authors:  A M LERNER; J S REMINGTON; M FINLAND
Journal:  J Clin Invest       Date:  1962-04       Impact factor: 14.808

3.  Isolation and characterization of a papovavirus from human urine.

Authors:  R M Dougherty; H S DiStefano
Journal:  Proc Soc Exp Biol Med       Date:  1974-06

4.  Papova virus in urine after renal transplantation.

Authors:  G Lecatsas; O W Prozesky; J van Wyk; H J Els
Journal:  Nature       Date:  1973-02-02       Impact factor: 49.962

5.  High prevalence of antibodies to BK virus, an SV40-related papovavirus, in residents of Maryland.

Authors:  K V Shah; R W Daniel; R M Warszawski
Journal:  J Infect Dis       Date:  1973-12       Impact factor: 5.226

6.  Search for BK and SV40 virus reactivation in renal transplant recipients.

Authors:  K V Shah; R W Daniel; R F Zeigel; G P Murphy
Journal:  Transplantation       Date:  1974-01-01       Impact factor: 4.939

7.  A study of "total therapy" of acute lymphocytic leukemia in children.

Authors:  P George; K Hernandez; O Hustu; L Borella; C Holton; D Pinkel
Journal:  J Pediatr       Date:  1968-03       Impact factor: 4.406

8.  Prevalence in England of antibody to human polyomavirus (B.k.).

Authors:  S D Gardner
Journal:  Br Med J       Date:  1973-01-13

9.  Human polyomavirus infection in renal allograft recipients.

Authors:  D V Coleman; S D Gardner; A M Field
Journal:  Br Med J       Date:  1973-08-18

10.  Experimental infection of rhesus with simian virus 40 (SV40).

Authors:  K V Shah; S Willard; R E Myers; D M Hess; R DiGiacomo
Journal:  Proc Soc Exp Biol Med       Date:  1969-01
View more
  26 in total

1.  Physical mapping of BK virus DNA with SacI, MboII, and AluI restriction endonucleases.

Authors:  R C Yang; R Wu
Journal:  J Virol       Date:  1978-12       Impact factor: 5.103

2.  Antibodies in urine of chimpanzees with chronic adenoviral viruria.

Authors:  L V Ashner; D M Asher; K V Shah; H L Amyx; C J Gibbs; D C Gajdusek
Journal:  Infect Immun       Date:  1978-08       Impact factor: 3.441

3.  BK virus: II. Serologic studies in children with congenital disease and patients with malignant tumors and immunodeficiencies.

Authors:  H J Rziha; B H Belohradsky; U Schneider; H U Schwenk; G W Bornkamm; H zur Hausen
Journal:  Med Microbiol Immunol       Date:  1978-07-04       Impact factor: 3.402

4.  Virus infections after transplantation in man. Brief review.

Authors:  M Ho
Journal:  Arch Virol       Date:  1977       Impact factor: 2.574

5.  Lymphocyte stimulation by urine-derived human polyoma virus (BK).

Authors:  G Lecatsas; E Blignaut; B D Schoub
Journal:  Arch Virol       Date:  1977       Impact factor: 2.574

6.  Isolation of a variant of BK virus with altered restriction endonuclease pattern.

Authors:  W Pauw; J Choufoer
Journal:  Arch Virol       Date:  1978       Impact factor: 2.574

Review 7.  Papovaviral persistent infections.

Authors:  L C Norkin
Journal:  Microbiol Rev       Date:  1982-12

8.  Reactivation of persistent papovavirus K infection in immunosuppressed mice.

Authors:  J E Greenlee; W K Dodd
Journal:  J Virol       Date:  1984-08       Impact factor: 5.103

9.  BK virus as a cofactor in the etiology of prostate cancer in its early stages.

Authors:  Dweepanita Das; Kirk Wojno; Michael J Imperiale
Journal:  J Virol       Date:  2007-12-26       Impact factor: 5.103

10.  BK antibody and virus-specific IgM responses in renal transplant recipients, patients with malignant disease, and healthy people.

Authors:  A J Flower; J E Banatvala; I L Chrystie
Journal:  Br Med J       Date:  1977-07-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.